Health care expenditures are increasing at an alarming rate in fee-for-service health systems like those in the U.S.; however, health outcomes are not. In less resourced parts of the world, lack of access to modern health care is the primary challenge. In both instances, there is a
critical need for disruptive innovations that will change the way patients move through the health care system and, ultimately, benefit from it. Successful innovations that disrupt the status quo will ideally result in decreased health care expenditures and improved health outcomes by reducing
the cost of existing technologies and infrastructure and eliminating the requirement for skilled intervention, thereby increasing access and consolidating touchpoints to eliminate potentially unnecessary visits as well as loss to follow up. With upcoming transitions to value-based care health
systems, where patient outcomes and expenditure are considered in the reimbursement model, these types of technologies will only grow in importance. Here, we show three case studies illustrating these concepts in the cervical and breast cancer care cascades and highlight the implications of
these innovations in the context of both local and global health. Democratizing health care by developing technologies that facilitate a transition to a value-based health care system is desperately needed to simultaneously reduce expenditures while improving outcomes.
No Supplementary Data.
No Article Media
POINT OF CARE DIAGNOSTICS;
Document Type: Research Article
August 1, 2019
More about this publication?
Technology and Innovation, edited and published by the National Academy of Inventors, is a forum for presenting information encompassing the entire field of applied sciences, with a focus on transformative technology and academic innovation. Regular features of T&I include commentaries contributed by the United States Patent and Trademark Office (USPTO) and in-depth profiles of Fellows of the National Academy of Inventors in every issue.